Big Pharma Bias: FDA Grants ‘Breakthrough’ Status to Ecstasy for PTSD While Prohibiting Pot

Cannabis and ecstasy are both Schedule 1 drugs and both show incredible promise for treating PTSD, but FDA only approves of the pharmaceutical one.